(Total Views: 99)
Posted On: 03/06/2023 1:05:48 PM
Post# of 74550

$MRK News Article - Merck's MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study https://marketwirenews.com/news-releases/merc...60048.html


My Twitter: WhyteStocks